Screener
Clover Health Investments CLOV Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $198.84M+5.4% | $173.27M+11.5% | $78.3M-59.8% | $190.06M-34.0% | $188.65M-26.0% | ||
| $2.48M+40.3% | $4.29M— | $17.05M— | $1.8M+1.2% | $1.77M-81.7% | ||
| $73.12M+55.9% | $73.47M+37.3% | $94.87M+84.1% | $57.94M+55.3% | $46.89M-29.7% | ||
| $485.45M+33.8% | $448.02M+35.2% | $307.86M-10.3% | $330.92M-23.5% | $362.94M-34.0% | ||
| $7.23M+39.0% | $6.9M+37.4% | $6.39M+20.3% | $5.49M+2.8% | $5.2M-1.4% | ||
| $2.99M0.0% | $2.99M0.0% | $2.99M0.0% | $2.99M0.0% | $2.99M0.0% | ||
| $243.25M+21.4% | $241.34M+2.5% | $224.04M-8.4% | $205.38M-14.7% | $200.44M-9.2% | ||
| $720.33M+25.3% | $697.73M+19.5% | $541.01M-6.8% | $559.66M-14.3% | $574.99M-14.7% | ||
| $35.41M+4.3% | $39.17M+28.2% | $36.21M+4.8% | $32.94M+27.9% | $33.95M-16.0% | ||
| $14.9M+1.4% | $14.8M-0.7% | $14.6M-0.7% | $14.9M0.0% | $14.7M-1.3% | ||
| $323.33M+60.1% | $336.58M+56.1% | $208.82M-2.2% | $193.45M-30.8% | $201.95M-37.8% | ||
| $344.07M+49.1% | $358.3M+44.7% | $232.31M-3.0% | $218.73M-29.6% | $230.81M-33.9% | ||
| -$2.23B-0.8% | -$2.26B-2.6% | -$2.29B-3.9% | -$2.24B-2.7% | -$2.21B-2.0% | ||
| $376.26M+9.3% | $339.43M+1.0% | $308.7M-9.5% | $340.93M-0.4% | $344.18M+5.9% | ||
| $720.33M+25.3% | $697.73M+19.5% | $541.01M-6.8% | $559.66M-14.3% | $574.99M-14.7% |
FAQ
- What are Clover Health Investments's total assets?
- Clover Health Investments (CLOV) holds $720.3M in total assets, up 25.3% year over year.
- How much cash does Clover Health Investments have?
- Clover Health Investments holds $198.8M in cash and equivalents.
- Can Clover Health Investments cover its short-term obligations?
- Its current ratio is 1.50 — current assets exceed current liabilities.
- Where does Clover Health Investments's balance sheet data come from?
- Every line is extracted from Clover Health Investments's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
